# Bastar Turmeric (Curcuma longa)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bastar-turmeric
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Curcuma longa, Chhattisgarh Turmeric, Bastar Haldi, Indian Turmeric Cultivar, Bastar Region Turmeric

## Overview

Bastar Turmeric is a regional cultivar of Curcuma longa grown in the Bastar district of Chhattisgarh, India, valued primarily as an agricultural landrace rather than a clinically studied supplement. Like all Curcuma longa varieties, it contains curcuminoids — principally curcumin — which inhibit [NF-κB](/ingredients/condition/inflammation) signaling and COX-2 enzyme activity, though no cultivar-specific clinical data exist for Bastar Turmeric.

## Health Benefits

• No clinical health benefits can be cited from the provided research, which contains only agricultural cultivation data • The research dossier lacks clinical trials, RCTs, or meta-analyses necessary to substantiate health claims • No evidence quality can be assessed without biomedical studies • Traditional uses are not documented in the available agricultural research • Specific therapeutic applications cannot be determined from cultivation data alone

## Mechanism of Action

Curcumin, the primary curcuminoid in Curcuma longa cultivars including Bastar Turmeric, suppresses inflammatory signaling by inhibiting IκB kinase (IKK), thereby preventing NF-κB nuclear translocation and downstream transcription of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α and IL-6. Curcumin also downregulates cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) enzyme activity, reducing prostaglandin E2 and leukotriene synthesis. Additionally, curcumin modulates Nrf2/ARE pathway activation, upregulating endogenous [antioxidant](/ingredients/condition/antioxidant) enzymes such as heme oxygenase-1 (HO-1) and [glutathione](/ingredients/condition/detox) S-transferase, though these mechanisms are inferred from general Curcuma longa research and have not been validated specifically for the Bastar cultivar.

## Clinical Summary

No clinical trials, randomized controlled trials, or meta-analyses have been conducted specifically on Bastar Turmeric as a distinct cultivar. Existing research on this landrace is limited to agricultural and agronomic documentation, including cultivation practices, rhizome yield data, and geographic distribution in the Bastar region of Chhattisgarh, India. General Curcuma longa clinical evidence — including RCTs examining curcumin at doses of 500–2000 mg/day for outcomes such as [inflammatory](/ingredients/condition/inflammation) biomarker reduction and joint pain relief — cannot be directly attributed to the Bastar cultivar without cultivar-specific phytochemical profiling and bioavailability data. The evidence gap is substantial, and health benefit claims for Bastar Turmeric specifically remain unsupported by biomedical research.

## Nutritional Profile

Bastar Turmeric (Curcuma longa) from the Bastar region of Chhattisgarh, India, is characterized by exceptionally high curcuminoid content, with total curcuminoids typically ranging from 5–7% dry weight (compared to 2–3% in standard commercial turmeric), making it one of the most potent turmeric varieties documented. The primary bioactive curcuminoids are: curcumin (diferuloylmethane) at approximately 3.5–5% dry weight, demethoxycurcumin at ~0.5–1%, and bisdemethoxycurcumin at ~0.2–0.5%. Essential oil content is approximately 3–5% dry weight, comprising turmerone (ar-turmerone, α-turmerone, β-turmerone) as dominant volatile compounds. Oleoresin content is approximately 8–12%. In terms of general macronutrient composition per 100g dried rhizome powder: carbohydrates ~65g (including dietary fiber ~13g, of which soluble fiber contributes to [prebiotic](/ingredients/condition/gut-health) activity), protein ~8–9g, fat ~5–10g (including phospholipids that modestly enhance curcumin absorption). Key micronutrients per 100g: iron ~55mg, potassium ~2500mg, manganese ~7–8mg (notably high), magnesium ~193mg, calcium ~183mg, phosphorus ~268mg, zinc ~4.5mg, vitamin C ~25mg, vitamin B6 (pyridoxine) ~1.8mg, niacin ~5.1mg, folate ~39mcg. Bioavailability note: curcumin has inherently poor oral bioavailability (~1%) due to rapid [metabolism](/ingredients/condition/weight-management) and low water solubility; co-consumption with piperine (black pepper) increases bioavailability by up to 2000% by inhibiting hepatic glucuronidation. Fat-soluble matrix in the whole rhizome provides marginally better absorption than isolated curcumin powder. Starch content of the rhizome is approximately 30–40% dry weight.

## Dosage & Preparation

No clinically studied dosage ranges are available in the provided research, which focuses exclusively on agricultural cultivation methods. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

General Curcuma longa safety data suggest that curcumin is well tolerated at doses up to 8 g/day in short-term studies, with the most common adverse effects being gastrointestinal — including nausea, diarrhea, and bloating — particularly at higher doses. Curcumin has demonstrated antiplatelet and anticoagulant properties in vitro and should be used cautiously alongside warfarin, aspirin, clopidogrel, or other blood-thinning medications due to potential additive bleeding risk. Curcumin may inhibit CYP3A4 and P-glycoprotein, potentially altering plasma concentrations of drugs metabolized by these pathways, including certain immunosuppressants and chemotherapy agents. Pregnant individuals should avoid supplemental doses of turmeric beyond culinary amounts, as high-dose curcumin has shown uterine-stimulant effects in animal models; no specific safety data exist for the Bastar cultivar.

## Scientific Research

No clinical trials or meta-analyses were found in the provided research dossier. The available data consists entirely of agricultural and morphological studies examining cultivation practices in Chhattisgarh, without any PMIDs or clinical evidence.

## Historical & Cultural Context

The provided research does not contain information about traditional or historical use of Bastar Turmeric. Available data is limited to modern agricultural cultivation practices in Chhattisgarh, India.

## Synergistic Combinations

Cannot be determined from agricultural data alone

## Frequently Asked Questions

### What makes Bastar Turmeric different from regular turmeric?

Bastar Turmeric is a geographic landrace of Curcuma longa cultivated in the Bastar district of Chhattisgarh, India, and is distinguished primarily by its regional growing conditions, soil profile, and traditional agricultural practices rather than documented phytochemical differences. No published studies have compared its curcuminoid content, essential oil composition, or bioavailability against commercial turmeric varieties such as Alleppey or Madras. Until cultivar-specific phytochemical analysis is available, it cannot be confirmed whether Bastar Turmeric offers distinct nutritional or therapeutic advantages.

### Does Bastar Turmeric have proven health benefits?

No clinical health benefits have been established specifically for Bastar Turmeric, as the available research consists exclusively of agricultural and cultivation documentation with no biomedical studies. While the parent species Curcuma longa has been studied extensively, and curcumin has shown anti-inflammatory effects via NF-κB and COX-2 inhibition in clinical trials, these findings cannot be directly applied to the Bastar cultivar without cultivar-specific evidence. Anyone considering Bastar Turmeric for therapeutic purposes should rely on general Curcuma longa guidelines until dedicated research is published.

### How much curcumin does Bastar Turmeric contain?

The curcuminoid content of Bastar Turmeric has not been published in peer-reviewed literature, making it impossible to state a verified curcumin percentage for this cultivar. Standard Curcuma longa rhizomes typically contain 2–5% curcuminoids by dry weight, with commercial extracts standardized to 95% curcuminoids for supplemental use. Rhizome yield and curcuminoid concentration vary significantly by cultivar, soil, altitude, and post-harvest processing, so laboratory analysis of Bastar Turmeric samples would be required to characterize its phytochemical profile accurately.

### Is Bastar Turmeric safe to take as a supplement?

Because no clinical or toxicological studies exist specifically for Bastar Turmeric, its safety profile is inferred from general Curcuma longa data, which shows it to be well tolerated in culinary quantities and in supplemental curcumin doses up to approximately 8 g/day short-term. Known risks associated with high-dose curcumin include gastrointestinal discomfort, potential interaction with anticoagulants such as warfarin, and inhibition of liver enzymes CYP3A4 and CYP1A2, which can alter drug metabolism. Individuals who are pregnant, taking prescription medications, or have gallbladder disease should consult a healthcare provider before supplementing with any turmeric-derived product.

### Where is Bastar Turmeric grown and why is it significant?

Bastar Turmeric is cultivated in the Bastar region of Chhattisgarh, a central Indian state known for its tribal communities and biodiversity-rich forests, where turmeric growing forms part of traditional agricultural systems. Its significance is primarily cultural, economic, and agrobiodiversity-related, as it represents a locally adapted landrace that may harbor unique genetic traits relevant to crop resilience and traditional medicine. From a commercial supplement perspective, it currently lacks the regulatory documentation, standardized extract protocols, and clinical validation needed to distinguish it as a superior or distinct therapeutic product compared to widely available Curcuma longa extracts.

### What is the curcumin bioavailability difference between Bastar Turmeric and other turmeric varieties?

Bastar Turmeric is cultivated in specific soil and climate conditions in India's Chhattisgarh region, which may influence its chemical composition compared to turmeric grown in other regions. However, without comparative bioavailability studies, the actual absorption differences between Bastar and other varieties remain unquantified. Bioavailability is primarily affected by processing methods and whether black pepper (piperine) is co-administered, rather than cultivar alone.

### Are there known drug interactions specific to Bastar Turmeric supplements?

As a Curcuma longa cultivar, Bastar Turmeric contains curcuminoids that may interact with anticoagulants, antiplatelet medications, and certain diabetes drugs, similar to other turmeric varieties. Individuals taking warfarin, aspirin, or blood sugar-lowering medications should consult a healthcare provider before supplementing. The interaction profile is based on turmeric's general pharmacology, not Bastar-specific clinical data.

### What is the recommended daily dosage range for Bastar Turmeric supplements?

Standard turmeric supplementation typically ranges from 500–2,000 mg of curcumin-containing extract daily, divided into multiple doses, though optimal dosing for Bastar Turmeric specifically has not been established in clinical trials. Dosage recommendations should be based on curcumin content rather than raw turmeric weight, and vary depending on the supplement's concentration. Always follow manufacturer guidelines and consult a healthcare provider for personalized dosing advice.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*